. A phase II randomized controlled study in sufferers with MSA assessing efficacy of oral sirolimus on slowing illness development was recently prematurely terminated mainly because meeting the futility standards https://albertykor453014.collectblogs.com/75674324/the-best-side-of-multiple-system-atrophy-physiotherapy